Expert guidelines, based on research evidence, to help clinicians provide care. They are produced by bodies such as the British HIV Association (BHIVA), the European AIDS Clinical Society (EACS) and the World Health Organization (WHO).

Treatment guidelines: latest news

Treatment guidelines resources

  • When to start treatment

    Until recently, doctors weren’t sure of the best time to start HIV treatment. In 2015 a large, well-conducted study demonstrated that there are advantages to starting treatment as...

    From: Booklets

    Information level Level 2
  • Starting HIV treatment

    It’s better to start HIV treatment sooner, rather than later.Treatment will reduce the risk of HIV transmission, prevent illnesses and extend your life.A range of different antiretroviral...

    From: Factsheets

    Information level Level 2
  • When to start treatment

    Until recently, doctors weren’t sure of the best time to start HIV treatment. However in 2015 a large, well-conducted study demonstrated that there are advantages to starting...

    From: Booklets

    Information level Level 2
  • HIV treatment as prevention

    This briefing paper, produced by NAM for HIV Prevention England, describes the scientific evidence for HIV treatment as prevention and considers its implications for the UK....

    From: HIV prevention briefing papers

Treatment guidelines features

Treatment guidelines news from aidsmap

More news

Treatment guidelines news selected from other sources

  • What's New in the U.S. HIV Clinical Guidelines

    We walk you through the most recent updates to official guidelines issued by the U.S. Department of Health and Human Services on the treatment and care of HIV.

    21 December 2018 |
  • How HIV Physicians Can Better Treat an Aging Population

    A research team has sought to address the critical lack of treatment guidelines for addressing HIV’s complex effects on aging.

    12 December 2018 | Poz
  • Brazil highlights treatment for all people with HIV

    Ahead of World AIDS Day 2018, the Government of Brazil has announced the largest drop in AIDS-related deaths in the country, as a result of Brazil’s policy for greater access to HIV prevention, testing, treatment and care.

    01 December 2018 | World Health Organization
  • Focus on HIV-2 Infection: A Clinician Roundtable

    Infectious Disease Advisor interviewed the following experts to discuss the challenges and clinical implications pertaining to HIV-2.

    04 September 2018 | Infectious Disease Advisor
  • Why the world may force women to choose: No birth control, no ARVs

    A new drug could save 25 000 women living with HIV but could it come at the cost of their babies lives?

    22 August 2018 | Bhekisisa
  • Australian doctors to tell HIV patients that 'undetectable=untransmissible'

    In what has been seen as major win for HIV advocates, the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) has released a guide to help doctors understand the ‘Undetectable=Untransmittable (U=U)’ campaign.

    24 July 2018 | Gay Star News
  • Dolutegravir: need to consider all pros and cons before switching in pregnancy

    A young pregnant woman who switched from dolutegravir (DTG)-based ART, in response to the neural tube defect safety signal, experienced viral rebound on her new regimen. She needed to be switched back to DTG to achieve re-suppression and prevent vertical transmission.

    11 July 2018 | HIV i-Base
  • All-access for blockbuster TB drug in South Africa

    The country made history on Monday when the health department announced that all drug-resistant tuberculosis (DR-TB) patients will be eligible to receive the new medicine, bedaquiline. “The Department of Health’s [DoH] commitment on bedaquiline is momentous globally and marks a new era of DR-TB management where we are really prioritising the patient,” Doctors Without Borders’ Dr Anja Reuters told Health-e News.

    19 June 2018 | Health-e
  • Starting HIV treatment at diagnosis slashes drop out, drug failure rates, China study finds

    Patients diagnosed with HIV who started antiretroviral treatment within 30 days had significantly lower rates of dropping out of treatment, and higher rates successful treatment, than those who started later, particularly those who started more than three months after their diagnosis, a study in China has found.

    04 June 2018 | Science Speaks
  • South Africa: Birth defects fears prompt warnings about new ARV

    Despite the public concern globally, very little has been said about the impact of the safety warning about dolutegravir on South Africa, the country with the largest HIV treatment programme in the world. The National Department of Health had already planned to introduce a dolutegravir-based first line regimen to replace the existing regimen, hoping to switch the majority of patients starting from last month.

    29 May 2018 | Health-e
More news
Tell us why you visited aidsmap today

Could you help us by answering three questions on why you’ve visited aidsmap today?

You can close this questionnaire and come back to it later. Just click on the pink circle.

What prompted you to visit aidsmap today?

What exactly are you looking for? What specific questions do you need answered?

Have you found what you were looking for?


Thank you for your feedback

Thank you very much for taking time to fill in this questionnaire. NAM really values your feedback. It helps make the information we provide better.

If you have any other comments on the content of this website, we would be interested to hear from you. Please email

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.

See also

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.